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Abstract 
 
Background: Renal transplantation is the best option for treatment of the end-stage renal diseases and has 
more advantages than dialysis. The objective of this study is to determine the ten-year graft survival rate of renal 
transplantation and its associated factors in patients who have been transplanted from March 1999 to March 
2009 in Nemazee Hospital Transplantation Center. 
 
Methods: This is a historical cohort study of 1356 renal transplantation carried out during 1999 to 2009. Kaplan-
Meier method was used to determine the survival rate, log rank test to compare survival curves, and Cox regres-
sion model to determine hazard ratios and for modeling of variables affecting survival.  
 
Results: The 1, 3, 5, 7 and 10 years graft survival rates were 96.6, 93.7, 88.9, 87.1 and 85.5 percent, respective-
ly. Cox regression model revealed that the donor source and creatinine level at discharge were effective factors 
in graft survival rate in renal transplantation.  
 
Conclusion: Our study showed that 10 year graft survival rate for renal transplantation in Nemazee Hospital 
Transplantation Center was 85.5% and graft survival rate was significantly related to recipients and donor’s age, 
donor source and creatinine level at discharge. Our experience in renal transplantation survival rate indicates a 
success rate comparable to those noted in other reports. 
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Introduction 
 
In the western world, using renal replacement therapy 
(dialysis and transplantation) for patients with end-
stage renal disease (ESRD) is going to be increased 
while the same epidemiological trend is also being 
seen in other countries and so is Iran.
1,2 In year 2006, 
there were 25000 patients with ESRD who were un-
der renal-replacement therapy in Iran and considering 
an annual growing rate of 12%, number can reach to 
40000 patients by the year 2011. The prevalence rate 
of ESRD has been reported to be 357 cases per one 
million populations per year.
1 These patients have 
been treated by dialysis and kidney transplantation.
3-6 
Kidney transplantation was the treatment of choice 
for ESRD
7,8 that restored the patients' quality of life 
and reduced the morbidity and mortality rates.
9,10  
Allograft rejection is the most important complication 
that reduces the graft survival after transplantation. 
Many variables contribute in survival or rejection of 
graft, such as donor source, age and gender, creati-
nine level, blood group, Rh type, waiting time, dura-
tion of hospitalization, vascular complications and 
acute rejection. The aim of this study was to deter-
mine the organ survival rate after kidney transplanta-
tion during a period of 10 years (1999-2009) in Shiraz 
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Transplant Center, Nemazee Hospital, Shiraz, South-
ern Iran. 
Materials and Methods 
 
This historical cohort study was intended to consider 
the graft survival rate in all patients (1356 cases) who 
received kidney transplantation in Shiraz Transplant 
Center, Nemazee Hospital, Shiraz, Southern Iran, 
during a period of 10 years from March 1999 to 
March 2009. The precise time of transplantation was 
considered to be the "initial event" and when renal 
allograft was diagnosed to be completely and irre-
versibly non-functioning due to any cause including 
rejection and the patient requirements regular dialysis 
again, was defined as "end-point event".  
We have not been performing preoperative donor 
conventional or computed tomography (CT) angi-
ography during the last 6 years of this period, and 
duplex ultrasonography and intravenous pyelography 
are the only imaging studies of the renal system of the 
donors that we used. CT angiography was used only 
when the duplex ultrasonography suggested any ab-
normal findings in renal vasculature. This selective 
use of contrast imaging studies prevents the use of 
excessive doses of intravenous contrast agents which 
may be toxic for the donor kidneys and warrants the 
safety of the donor surgery and picks up an occasion-
al donor with renovascular pathology. We prefer left 
kidney because of longer renal vein and better acces-
sibility for nephrectomy and use the right kidney only 
in special situations. 
The studied variables compromised donor's and 
recipient's age, gender (male/female and same or 
compatible), blood group (ABO and same or compat-
ible), and recipient's immunosuppressive drug regi-
men, recipient's job, underlying cause of ESRD, do-
nor source, time of first urination, vascular complica-
tion, endarterectomy, allograft warm and cold is-
chemic times, creatinine level at discharge and the 
duration of dialysis therapy before and hospital stay 
after transplantation. We used intravenous 
methylprednisolone for induction of immunosuppres-
sive regimen for all patients. Four different regimens 
had been prescribed to recipients for maintenance 
immunosuppressive regimen including i) Oral Predni-
solone, Azathioprine (Imuran®) and Cyclosporine 
(Neoral®), ii) Oral prednisolone, mycophenolate mo-
fetil (Cellcept®) and cyclosporine (Neoral®), iii) 
Oral prednisolone, azathioprine which was changed 
to mycophenolate mofetil (Cellcept®) after different 
time intervals and cyclosporine (Neoral®) and iv) 
Oral prednisolone, mycophenolate mofetil (Cell-
cept®) and tacrolimus (Prograf®). 
All needed data were collected through reviewing 
of patients' hospital records. The organ survival and 
every patient's need to regular dialysis were assessed 
and determined by nephrologists and recorded in fol-
low-up clinics and related institutions such as "Man-
agement Center for Transplantation and Special Dis-
eases" and "Renal Patients Support Society". Allo-
graft survival rate was calculated by Kaplan-Meier 
method and Log-rank test was used to compare sur-
vival curves and Cox Regression Models to define the 
hazard ratio and for modeling of factors implicating in 
survival rate. The SPSS® software (version16, Chica-
go, IL, USA) and STATA (version 9 for assessment 
proportionality of hazard ratio assumption) were used 
for statistical analysis of data. The P-value of less than 
0.05 was considered to be statistically significant. 
 
 
Results  
 
One thousands and three hundred and fifty six cases 
of kidney transplantation were performed in Shiraz 
Transplant Center, Nemazee Hospital, during a period 
of 10 years (1999-2009). Out of these, 403 (29.7%) 
kidneys were from living related donors, 441 (32.5%) 
kidneys from living unrelated donors and 512 
(37.8%) kidneys from deceased donors. We could 
follow 1288 (94.9%) out of 1356 patients who had 
received kidney and found that 107 (7.9%) of them 
had been eventuated in irreversibly non-functioning 
allografts that necessitated regular dialysis again. The 
mean age of kidney donors and recipients were 
34.99±13.94 and 31±11.21 years, respectively. The 
mean duration of hospital stay and duration of dialy-
sis before operation were 12.29±5.63 days and 
15.93±14.52 months, respectively, and mean follow-
up period was 47.23±33.33 months. 
The age of donors and recipients in 94.5 and 
84.2% of cases were less than 50 years old, respec-
tively. 64.4 percent of recipients were male and 
35.6% were female. The males and females com-
prised 65.9 and 34.1% of donors respectively, and 
41.7% of transplantations were performed from male 
to male. Blood type of “O” has been the most fre-
quent blood type among recipients and donors with 
43.3 and 50.4% of cases respectively, and blood 
group and Rh of donor and recipient in 85% of cases 
were identical. Considering creatinine level status at 
discharge, in 85.5% of recipients was 2 mg/dl or less. Almasi-Hashiani et al. 
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Warm and cold ischemia time in 100 and 57.6% of 
cases were less than 2 hours, respectively. Endarter-
ectomy was not performed in 92.1% of cases and in 
92.3% of cases; the first time to urination was imme-
diate. In 61.7% of cases, the duration of hospitaliza-
tion after operation was from 7 to 14 days. The under-
lying cause of ESRD was mostly unknown (compris-
ing 53.9% of cases). However, the most common di-
agnosed renal disease leading to ESRD was glomeru-
lonephritis (in 27.7% of cases). The first regimen was 
the most frequently used immunosuppressive therapy 
which had been administered in nearly 49.3% of cases.  
As shown in Figure 1, the calculated survival rate 
of 1, 3, 5, 7, 10 year for renal transplantation using 
Kaplan-Meier method was 96.6, 93.7, 88.9, 87.1 and 
85.5%, respectively. For investigating the existence 
of any significant difference among the different clas-
ses of these variables from the point of survival rate, 
Log-rank method calculated p-values, have been cal-
culated and age of donor (p=0.005), donor source 
(p=0.001), HCV infection (p=0.029), creatinine level 
at discharge (p=0.001), and duration of hospitaliza-
tion after operation (p=0.017) showed significant re-
lationship with renal transplantation graft survival 
rate. In the other variables, there was no significant 
difference among their graft survival curves. 
 
 
Fig. 1: Allograft survival rate in renal transplant recipients. 
 
Using Cox proportional hazard model that was 
shown in Table 1, we found that donor source and 
creatinine level at discharge (as shown in Figure 2 
and 3) had a significant relationship with graft sur-
vival rate. Hazard ratio in deceased-donor transplan-
tation compared to living-related donor has been 2.56 
(CI=1.36–4.78,  p=0.003). Also, in the cases which 
discharge time, the creatinine level was more than 2 
mg/dl in comparison to cases with creatinine level of 
2 mg/dl or less and a hazard ratio of 3.97 (CI=2.3–
6.8, p=0.001). 
 
 
Fig. 2: Allograft survival rate in renal transplant recip-
ients based on donor source.  
 
 
Discussion  
 
In this study, the survival rate of 1, 3, 5, 7, and 10- 
years have been 96.6, 93.7, 88.9, 87.1, and 85.8% 
respectively. According to the report of Iranian 
Network for Organ Procurement, one- year survival 
rate in Iran taps around 95%, a result which is simi-
lar to our study. 
Table 1: Multivariate analysis by Cox Regression Model
Variables Hazard  ratio P value 95 % CI for hazard ratio 
Lower limit Upper limit 
Donor source  
Related 
Unrelated 
Deceased  
 
1 
1.04 
2.56 
 
- 
0.8 
0.003 
 
- 
0.51 
1.36 
 
- 
2.12 
4.78 
Creatinine at dis-
charge 2≥ mg/dl 
>2 mg/dl 
 
1 
3.97 
 
- 
0.001 
 
- 
2.3 
 
- 
6.8 Graft survival in renal transplantation 
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Fig. 3: Allograft survival rate in renal transplant   
recipients based on creatinine level at discharge. 
 
Using Kaplan-Meier method, the age of donor has 
been known as one of the contributor factor on sur-
vival rate. A lot of studies have been conducted upon 
above mentioned issue which some of them are stud-
ies of Briganti
11 and Orsenigo et al.,
12 which showed 
that the age of donor and recipient are of contributing 
variables. These results have been confirmed by plen-
ty of other studies,
13-17 but using Cox proportional 
hazard model we found that the age of donors and 
recipients were not significant with graft survival rate 
of renal transplantation. 
Many studies have shown that there is no signifi-
cant relationship between the gender of graft donor and 
recipient with survival rate of transplantation
11,13,17 and 
our study is another evidence for this correlation. One 
of the effective variables on survival rate which also 
has been studied,
11,13 is the donor source (living- relat-
ed donor, living- unrelated donor and deceased-donor). 
In this study, this factor was also determined and re-
vealed that the living- donor survival rate is signifi-
cantly higher in comparison with deceased donor. Al-
beit that is true, using deceased organs is one of the 
major strategies for shortening the waiting time for 
transplantation, following that, the time of pre- opera-
tion dialysis which can be one of the important factors 
on survival rate decreases. 
Briganti  et al.,
11 Mohamed et al.,
16 and Bruce 
Kaplan et al.,
14 reported that the increase of cold is-
chemia time leads to the decrease of transplantation 
survival rate significantly. On the other hand in the 
study that Courtney et al.
13 conducted, there was no 
significant relationship between survival rate and cold 
ischemia time which is similar to our study findings. 
One of the reasons for differences in observed results 
might be the incomplete registration of cold ischemia 
time in our study, since in this study, only in 55.3% 
of cases, cold ischemia time was etermined. 
In many studies, the graft and patient’s survival 
rate in HCV positive and negative groups has been 
reported equal.
18-21 On the other hand, in some studies 
the graft survival rate for HCV negative cases in 
comparison to HCV positive cases have been signifi-
cantly higher,
16,22 and this study also confirms that 
graft survival rate in different HCV donors group was 
not significant. 
In this study, the graft survival rate between dif-
ferent occupational groups was not significant. Also, 
having or not having the history of endarterectomy, 
iliac type of vein and artery and the number of used 
veins and arteries (simple, double and triple) have not 
shown significant relationship with survival rate. A 
lot of studies, including Courtney et al.'s study,
13 have 
shown that the cause of ESRD is one of those factors 
that have this potential to influence the graft survival 
rate of kidney transplantation. On the other hand 
some reports have represented that there is no signifi-
cant relationship between survival rate and the cause 
of ESRD.
11,23, 24  In this study, there was no significant 
relationship between survival rate and primary renal 
disease too, albeit this should be mentioned that in 
over the 50% of the cases (53.9%) the reason of 
ESRD was not clear.   
Cox regression model demonstrated that duration 
of dialysis before operation had no significant rela-
tionship with the survival rate and this finding is simi-
lar to other results.
25 On the other hand, in some re-
ports, there was a significant correlation between 
graft survival rate of transplantation and duration of 
dialysis before operation.
11,26 The right or left being of 
donor kidney was from those variables which had not 
significant relationship with survival rate. In most 
cases, the left kidney because of having a longer vein 
was selected for transplantation and in this study 
composed 98% of the cases among whom, the left or 
right side of kidney was known. 
The duration of post-operation hospitalization is 
another independent variable which had influence on 
the survival rate while in the final model had no sig-
nificant relationship with survival rate. In recent 
years, there has been a descending trend in the period 
of patient hospitalization and in the recent decade, the 
period of hospitalization in renal transplantation has 
decreased from 12.7-19 days to 5-7.5.
27,28 Lin’s study Almasi-Hashiani et al. 
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showed that less than 4 days hospitalization would be 
one of the possible effective factors of the reduction 
of survival rate and patient survival in the long run.
28  
In recent years, the progress in immunosuppressive 
regimen has led to improvement of transplantation 
survival rate and patient’s survival rate, but in this 
study, no significant relationship between immuno-
suppressive drug regimen and graft survival rate was 
noticed and also in other studies, there was no associ-
ation between immunosuppressive regimen and the 
survival rate.
26,27,29 
Creatinine level at discharge was another variable 
which showed a significant relationship with the sur-
vival rate of kidney transplantation on Cox model 
which is similar to Rayhill's et al.'s study,
30 Based on 
Rayhill's et al.'s study, per one singular unit increased 
the creatinine level and the transplantation risk ratio 
increased 1.8 times.     
Our study showed that 10 year graft survival rate 
for renal transplantation in Nemazee Hospital Trans-
plantation Center was 85.5% and graft survival rate 
was significantly related to recipients and donor’s 
age, donor source and creatinine level at discharge. 
Our experience in renal transplantation survival rate 
indicates a success rate comparable to those noted in 
other reports. 
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